Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice
RecruitingOBSERVATIONAL
Enrollment
70
Participants
Timeline
Start Date
April 2, 2025
Primary Completion Date
September 12, 2028
Study Completion Date
September 12, 2028
Conditions
MAFLD
Trial Locations (1)
125008
RECRUITING
Center of Target Therapy LLC., Moscow
All Listed Sponsors
lead
Center of target therapy
OTHER
NCT06983171 - Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice | Biotech Hunter | Biotech Hunter